Autonomic dysfunction and anemia in neurologic disorders.
The effect of autonomic dysfunctions on anemia in various neurological disorders, such as familial amyloidotic polyneuropathy (FAP) Type I, pandysautonomia, and Shy-Drager syndrome was examined. As a control, hemograms of patients with amyotrophic lateral sclerosis (ALS), which is known to be free from autonomic dysfunction, was compared with patients with the above neurological disorders. FAP and pandysautonomia patients showed significant anemia comparable with the severity of the autonomic dysfunctions. Shy-Drager patients exhibited mild anemia. However, in ALS patients, no such anemia was recognized at all even in the end stage of this disease. In pandysautonomia patients, hypoplastic bone marrow was recognized, which was quite consistent with the data previously reported in FAP patients. Human recombinant erythropoietin improved orthostatic hypotension as well as anemia in 4 FAP patients. These results suggest that autonomic dysfunction may be deeply connected with erythropoiesis.
Ando
Y
Y
First Department of Internal Medicine, Kumamoto University School of Medicine, Japan.
Asahara
K
K
Obayashi
K
K
Suhr
O
O
Yonemitsu
M
M
Yamashita
T
T
Tashima
K
K
Uchino
M
M
Ando
M
M
D000328:Adult; D000368:Aged; D017772:Amyloid Neuropathies / Q000150:complications*; D000690:Amyotrophic Lateral Sclerosis / Q000150:complications*; D000740:Anemia / Q000150:complications* / Q000188:drug therapy; D001707:Biopsy, Needle; D001853:Bone Marrow / Q000473:pathology; D004921:Erythropoietin / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011115:Polyneuropathies / Q000150:complications; D011994:Recombinant Proteins; D012791:Shy-Drager Syndrome / Q000150:complications*
D011994:Recombinant Proteins; D004921:Erythropoietin